Enveric Biosciences Inc vs Super Micro Computer Inc — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while Super Micro Computer Inc trades at $43.32 (market cap $28.10B). The key difference: Super Micro Computer Inc is far larger — about 4132.4× Enveric Biosciences Inc's market cap, and Super Micro Computer Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Super Micro Computer Inc for 19 Days on average.
| ENVB | SMCI | |
|---|---|---|
Market Cap | $6.80M | $28.10B |
Volume | 64,867 | 38,581,805 |
Sector | Health | Technology |
52-Week High | $10.80 | $57.98 |
52-Week Low | $1.27 | $20.53 |
Typical Hold Time | 14 Days | 19 Days |
Enterprise Value | -$1.49M | $33.56B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
Super Micro Computer (SMCI) trades at $44.95, up 3.43% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $22B to $39.1B projected for 2026, net income margin expansion to 5.7%, and consistent earnings beats. Recent AI server demand and NVIDIA Vera Rubin shipments highlight business momentum, though RSI levels suggest potential near-term overbought conditions.
SMCI presents a compelling growth story with AI infrastructure expansion driving financial performance, trading at attractive valuations (P/E 13.12, P/S 0.76). However, investors face risks including margin pressure, competitive AI server market dynamics, and ongoing regulatory investigation. Analyst consensus remains mixed with 36% buy ratings despite price target below current levels at $42.33.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →